Parke S
No ORCID on file
· 5 papers in corpus
· active 2011-2026
Study types
- article 3
- rct 1
Condition tags
- endometriosis 1
- chronic_pelvic_pain 1
Top journals
Frequent coauthors
- Susanne Parke 3
- Serrani M 2
- Cho CH 1
- Christian Seitz 1
- Dong L 1
- Fraser IS 1
- Faustmann T 1
- Fabrizio Messina 1
- Groettrup-Wolfers E 1
- Chang Q 1
2026
Background/Objectives: Vilaprisan and ulipristal acetate (UPA) have demonstrated efficacy in treating uterine fibroids (UFs). However, a direct comparison of vilaprisan and UPA has been restricted, to date, to a small phase 2 study. Here, w…
rct
2024
BACKGROUND: The SCHUMANN study evaluated the efficacy and safety of the selective P2 × 3 antagonist eliapixant in patients with endometriosis-associated pelvic pain (EAPP). METHODS: SCHUMANN was a randomized, placebo- and active comparator…
article
2018
BACKGROUND: To investigate the efficacy and safety of a combined oral contraceptive containing estradiol valerate and dienogest (EV/DNG) in healthy Asian women. METHODS: In this multicenter Phase III study, women received oral EV/DNG in a 2…
article
2011
OBJECTIVES: To evaluate the efficacy of oestradiol valerate/dienogest (E2V/DNG) for the treatment of heavy and/or prolonged menstrual bleeding without organic pathology based on the analysis of data from two identically designed double-blin…
article
2011
BACKGROUND: The purpose of this study was to investigate the endometrial safety of an oral contraceptive containing estradiol valerate/dienogest (E(2)V/DNG) administered as an estrogen step-down and progestogen step-up regimen in women of r…